Sample Size and Power Calculations Based on Endpoint Responsiveness: Applications to Trials of Disease-Modifying Therapies in Parkinson’s Disease

Oct 6, 2026

M Pedrera Gomez

medRxiv preprint doi: https://doi.org/10.64898/2026.09.29.26363876

Responsiveness of a smartphone-based sensor-derived composite endpoint in a Phase 2b study in Parkinson’s disease ›